Cargando…
Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis.
Two patients with relapsed Wilms' tumour and renal failure requiring dialysis were given carboplatin and etoposide by pharmacokinetically guided dosing. The target area under the drug plasma concentration vs time curve (AUC) was 6 mg ml-1 min for carboplatin and 18 and 21 mg ml-1 min for etopos...
Autores principales: | English, M. W., Lowis, S. P., Peng, B., Boddy, A., Newell, D. R., Price, L., Pearson, A. D. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1996
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074374/ https://www.ncbi.nlm.nih.gov/pubmed/8611379 |
Ejemplares similares
-
A study of the feasibility and accuracy of pharmacokinetically guided etoposide dosing in children.
por: Lowis, S. P., et al.
Publicado: (1998) -
Platinum-DNA adduct formation in leucocytes of children in relation to pharmacokinetics after cisplatin and carboplatin therapy.
por: Peng, B., et al.
Publicado: (1997) -
Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis
por: Nijstad, A. Laura, et al.
Publicado: (2020) -
A phase I and pharmacokinetic study of intraperitoneal carboplatin and etoposide.
por: McClay, E. F., et al.
Publicado: (1993) -
Continuous ambulatory peritoneal dialysis: pharmacokinetics and clinical outcome of paclitaxel and carboplatin treatment
por: Heijns, Joan B., et al.
Publicado: (2008)